2024 Approvals
Duvyzat: A New Treatment for Duchenne Muscular Dystrophy Approved on March 21, 2024
What is it prescribed for? DUVYZAT is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older. What is the name of the drug and what does it do? Duvyzat (pronounced doo-VY-zat), (generic name: givinostat), is a medication indicated